Isoflavones Market is anticipated to witness considerable gains by 2032 on account of expanding nutraceutical industry in Asia Pacific. Growing consumer awareness about healthy diets influenced by the pandemic has proliferated the demand for dietary supplements in the region, paving the way for industry growth. As per the Ministry of Food Processing Industries data, India’s nutraceutical market is poised to reach USD 18 billion by 2025.

Isoflavones supplements have gained huge popularity in alleviating menopausal symptoms and offer protection against age-related diseases such as osteoporosis, cardiovascular disorders, and others. As per CDC, stroke affects over 795,000 people annually in the U.S. alone. Therefore, the rising prevalence of these disorders will propel the demand for nutraceuticals in the region, thus, transforming market dynamics.

Based on source, isoflavones industry from red clover segment is slated to record a valuation of more than USD 1.5 billion by 2032, owing to rising health consciousness among consumers. Healthy eating patterns have bolstered the demand for plant protein ingredients such as red clover. Moreover, red clover helps manage various conditions, such as whooping cough, gout, asthma, and cancer, while relieving osteoporosis and menopause symptoms.

With respect to application, isoflavones market from cosmetics segment is expected to garner significant gains through 2032. Isoflavones have gained immense traction as a skincare ingredient across the cosmetic sector, owing to their anti-aging and antioxidant properties. Additionally, they help maintain the pH balance, which makes them suitable for luxury and prescription cosmetics. Expanding cosmetics industry in developing European economies, such as France, Poland, Italy, and Germany, is likely to bolster segment gains during 2023-2032.

In terms of the regional landscape, Asia Pacific isoflavones industry is poised to grow at over 5.5% CAGR from 2023 to 2032 on account of surging occurrence of diabetes and cardiovascular disorders. As per WHO, nearly 77 million people in India 18 years and above are type 2 diabetic, and about 25 million are prediabetic. Growing prevalence of these disorders has increased consumer preferences toward nutraceuticals, which is likely to bolster the demand for isoflavones in the region.